Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$24,434
+$7,116 QoQ
Shares Held
950
+5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#222
of 290 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. DNLI ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,434 | 950 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,318 | 902 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,769 | 834 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $10,105 | 696 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,169 | 441 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $7,259 | 534 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $20,644 | 1,013 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $34,023 | 1,168 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $37,522 | 1,616 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $15,451 | 753 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $10,707 | 499 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $17,328 | 840 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $17,263 | 585 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $15,113 | 656 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $12,708 | 457 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,436 | 503 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $13,448 | 457 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $17,982 | 559 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $19,802 | 444 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,097 | 438 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $37,494 | 478 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $26,608 | 466 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $33,085 | 395 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $5,052 | 141 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $2,031 | 84 | Shares | Defined | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||